Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cecily Allen"'
Publikováno v:
Life, Vol 11, Iss 6, p 465 (2021)
Nearly four decades after their conceptualization, antibody-based therapies are slowly being added to the treatment landscape of acute myeloid leukemia (AML). While the antibody–drug conjugate gemtuzumab ozogamicin is the only antibody-based therap
Externí odkaz:
https://doaj.org/article/52a9089ea268409a84368794799121ec
Autor:
Cecily Allen, Samir Gautam, Wei Cheng, Alexander B. Pine, Nikolai A. Podoltsev, Amer M Zeidan, Alfred I Lee, Rory M. Shallis
Publikováno v:
Acta Haematologica. :1-6
Patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) often receive antibacterial prophylaxis. Antibacterial agents can cause elevations in the prothrombin time and international normalized ratio (INR). The impact of prophylac
Autor:
Cecily Allen, Ayesha Butt, Xiwen Zhao, Fangyong Li, Parveen Bahel, C-Hong Chang, Hyung Chun, Sean Gu, John Hwa, Sofia Jakab, Bonnie Chen, Guadalupe Garcia-Tsao, Henry Rinder, Uyen To, Matthew McConnell, Alfred I Lee, Alexander Pine
Publikováno v:
Blood. 140:8382-8383
Autor:
Nikolai A. Podoltsev, Maximilian Stahl, Alyssa Grimshaw, Christina Cho, Jan Philipp Bewersdorf, Amer M. Zeidan, Cecily Allen, Smith Giri, Abu-Sayeef Mirza, Lohith Gowda, Martin S. Tallman
Publikováno v:
Transplant Cell Ther
BACKGROUND: Disease relapse remains the major cause of death among patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) who receive an allogeneic hematopoietic cell transplant (allo-HCT). Maintenance treatment with FLT3 inhib